Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Net Income Loss of $4.70 million for the year ending 2025.
- CHAMPIONS ONCOLOGY, INC. showed an increase of +164.6% in Net Income Loss from 2024 to 2025.
- This data is from CHAMPIONS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on July 23, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), CHAMPIONS ONCOLOGY, INC.'s Net Income Loss has grown by 223.6%.
- Historical annual values: Fiscal year 2025: $4.70 million | Fiscal year 2024: -$7.28 million | Fiscal year 2023: -$5.34 million | Fiscal year 2022: $548.0 thousand | Fiscal year 2021: $362.0 thousand | Fiscal year 2020: -$2.09 million | Fiscal year 2019: $128.0 thousand | Fiscal year 2018: -$1.48 million | Fiscal year 2017: -$6.88 million | Fiscal year 2016: -$10.45 million | Fiscal year 2015: -$13.14 million | Fiscal year 2014: -$7.41 million | Fiscal year 2013: -$6.33 million | Fiscal year 2012: -$8.66 million | Fiscal year 2011: -$3.80 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: